A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice.
Our experiments were designed to determine whether recombinant ribonuclease inhibitor (RNasin) could inhibit angiogenesis and reduce tumor growth in adult mice. We used the Fajardo disc angiogenesis assay as the primary means of measuring new blood vessel growth. This assay measures the penetration of cells into a polyvinyl alcohol sponge with a central core of ELVAX-coated sponge containing test substances. Cell penetration was reduced to 29.3% of control (phosphate-buffered saline; heat-inactivated RNasin) values. Endothelial cell influx was measured by lectin staining and confirmed by culturing cells isolated from sponges by collagenase treatment. RNasin also reduced the augmented reaction evoked by either basic fibroblast growth factor (bFGF) or sodium orthovanadate. To confirm the anti-angiogenic activity of RNasin, Hydron-coated polyvinyl sponges containing bFGF or bFGF plus RNasin were implanted into adult mouse corneas. bFGF induced a strong angiogenic response that was almost completely inhibited by RNasin. RNasin-containing ELVAX-coated sponges implanted subcutaneously underneath an intradermal inoculum of C755 mammary tumor cells caused significant reduction in tumor growth (P < 0.005). The antitumor effect of RNasin correlated with its effect on tumor-induced neovascularization, suggesting that the ability of RNasin to affect tumor growth was due to its ability to inhibit angiogenesis.
Polakowski
I J
IJ
Center for Developmental Biology, University of Wisconsin, Madison 53706.
Lewis
M K
MK
Muthukkaruppan
V R
VR
Erdman
B
B
Kubai
L
L
Auerbach
R
R
D000230:Adenocarcinoma / Q000098:blood supply*; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D002478:Cells, Cultured; D016510:Corneal Neovascularization / Q000517:prevention & control; D004730:Endothelium, Vascular / Q000187:drug effects / Q000254:growth & development; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009389:Neovascularization, Pathologic / Q000473:pathology / Q000517:prevention & control*; D010926:Placental Hormones / Q000494:pharmacology*; D012260:Ribonucleases / Q000037:antagonists & inhibitors*; D012878:Skin Neoplasms / Q000098:blood supply*; D014407:Tumor Cells, Cultured
D010926:Placental Hormones; C022052:placental ribonuclease inhibitor; D012260:Ribonucleases